Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 4 - Number 6




Synthesis and Anti-HSV-1 Activity of 1,4-dihydro-4-oxoquinoline Ribonucleosides

, 4(6): 404 - 409

Carla Veronica B. dos S. Canuto, Claudia R. B. Gomes, Isakelly P. Marques, Leticia V. Faro, Fernanda da Costa Santos, Izabel Christina de P. P. Frugulhetti, Thiago M. L. e Souza, Anna C.Cunha, Gilberto A. Romeiro, Vitor F. Ferreira and Maria Cecilia B.V.de Souza


DOI: 10.2174/157018007781387818




The Molecular Basis of COX-2 Versus COX-1 Selectivity of Lumiracoxib by Molecular Docking Studies

, 4(6): 422 - 425

Celia M. Correa, Andre F. de Paula, Gilberto M.S. da Silva, Carlos M.R. Sant'Anna, Carlos A. M. Fraga and Eliezer J. Barreiro


DOI: 10.2174/157018007781387737




Preparation and Biological Activities of Heteroarotinoids

, 4(6): 442 - 445

Akimori Wada, Yukari Mizuguchi, Hiromi Miyake, Miki Niihara, Masayoshi Ito, Kimie Nakagawa and Toshio Okano


DOI: 10.2174/157018007781387827





Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)
Biography
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog